Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib in COVID-19 Pneumonia
NCT04750317Phase 2Completed
- Sponsor
- Sechenov First Moscow State Medical University
- Start
- May 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tofacitinib in COVID-19 pneumonia, sponsored by Sechenov First Moscow State Medical University. Started May 2020; status: completed.
02
Drugs
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04750317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04750317.